Vivos Therapeutics

Vivos Therapeutics

Health Care Equipment & Supplies
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

$2.7M

Market Cap • 9/28/2026

2016

(10 years)

Founded

2020

(6 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0

P/S

0,1

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

9,7

EPS

—

Market Cap

Market Cap

2,7M

EV

13,3M

EV/Revenue

0,6

EV/EBITDA

-0,6

EV/EBIT

-0,6

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-465,2%

Total Yield

-465,2%

Payout

0%

Profitability

Gross Margin

61,9%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

9%

Capex/D&A

105,1%

Capex/OCF

-11%

SBC/OCF

—

% PPE

30,9%

% Goodwill

35,5%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

7,5%

CAGR Op. Income 5Y

7,7%

CAGR Net Income 5Y

10,6%

CAGR EPS 5Y

-44,4%

CAGR OCF 5Y

7,7%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

0,2

Quick Ratio

0,2

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium